[1. Haldorsen IS, Kråkenes J, Krossnes BK, Mella O, Espeland A. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. AJNR Am J Neuroradiol 2009; 30: 744-51.10.3174/ajnr.A1447]Search in Google Scholar
[2. Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000; 92: 261-6.10.3171/jns.2000.92.2.0261]Search in Google Scholar
[3. Schlegel U, Schmidt-Wolf IG, Deckert M. Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci 2000; 181: 1-12.10.1016/S0022-510X(00)00385-3]Search in Google Scholar
[4. Olson JE, Janney CA, Rao RD, Cerhan JR, Kurtin PJ, Schiff D, et al. The continuing increase in the incidence of primary central nervous system non- Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 2002; 95: 1504-10.10.1002/cncr.10851]Search in Google Scholar
[5. Geppert M, Ostertag CB, Seitz G, Kiessling M. Glucocorticoid therapy obscures the diagnosis of cerebral lymphoma. Acta Neuropathol 1990; 80: 629-34.10.1007/BF00307631]Search in Google Scholar
[6. Zhang D, Hu L-B, Henning TD, Ravarani EM, Zou LG, Feng XY, et al. MRI findings of primary CNS lymphoma in 26 immunocompetent patients. Korean J Radiol 2010; 11: 269-77.10.3348/kjr.2010.11.3.269]Search in Google Scholar
[7. Bühring U, Herrlinger U, Krings T, Thiex R, Weller M, Küker W. MRI features of primary central nervous system lymphomas at presentation. Neurology 2001; 57: 393-6.10.1212/WNL.57.3.393]Search in Google Scholar
[8. Jenkins CN, Colquhoun IR. Characterization of primary intracranial lymphoma by computed tomography: an analysis of 36 cases and a review of the literature with particular reference to calcification haemorrhage and cyst formation. Clin Radiol 1998; 53: 428-34.10.1016/S0009-9260(98)80271-7]Search in Google Scholar
[9. Ueda F, Takashima T, Suzuki M, Kadoya M, Yamashita J, Kida T. MR imaging of primary intracranial malignant lymphoma. Radiat Med 1995; 13: 51-7.]Search in Google Scholar
[10. Coulon A, Lafitte F, Hoang-Xuan K, Martin-Duverneuil N, Mokhtari K, Blustajn J, et al. Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur Radiol 2002; 12: 329-40.10.1007/s00330010103711870430]Search in Google Scholar
[11. Haldorsen IS, Espeland A, Larsson E-M. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 2011; 32: 984-92.10.3174/ajnr.A2171801315720616176]Search in Google Scholar
[12. Yamashita K, Yoshiura T, Hiwatashi A, Togao O, Yoshimoto K, Suzuki SO, et al. Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ą⁸F-fluorodeoxyglucose positron emission tomography. Neuroradiology 2013; 55: 135-43.10.1007/s00234-012-1089-622961074]Search in Google Scholar
[13. Kim HS, Jahng GH, Ryu CW, Kim SY. Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol 2009; 30: 1574-9.10.3174/ajnr.A1635705162619461062]Search in Google Scholar
[14. Radbruch A, Wiestler B, Kramp L, Lutz K, Bäumer P, Weiler M, et al. Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging. Eur J Radiol 2013; 82: 552-6.10.1016/j.ejrad.2012.11.00223238364]Search in Google Scholar
[15. Peters S, Knöß N, Wodarg F, Cnyrim C, Jansen O. Glioblastomas vs. lymphomas: more diagnostic certainty by using susceptibility-weighted imaging (SWI). Rofo 2012; 184: 713-8.10.1055/s-0032-131286222618484]Search in Google Scholar
[16. Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M. Hemorrhage and VEGF expression in a case of primary CNS lymphoma. J Neurooncol 2002; 58: 53-6.10.1023/A:1015887312455]Search in Google Scholar
[17. Kim IY, Jung S, Jung TY, Kang SS, Choi C. Primary central nervous system lymphoma presenting as an acute massive intracerebral hemorrhage: case report with immunohistochemical study. Surg Neurol 2008; 70: 308-11.10.1016/j.surneu.2007.04.00918207523]Search in Google Scholar
[18. Kimura N, Ishibashi M, Masuda T, Ito M, Takahashi Y, Kumamoto T. Primary central nervous system lymphoma with cortical laminar hemorrhage. J Neurol Sci 2009; 287: 281-4.10.1016/j.jns.2009.07.02219699492]Search in Google Scholar
[19. Kickingereder P, Wiestler B, Sahm F, Heiland S, Roethke M, Schlemmer HP, et al. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility- weighted MR imaging. Radiology 2014; 272: 843-50.10.1148/radiol.1413274024814181]Search in Google Scholar
[20. Higano S, Yun X, Kumabe T, Watanabe M, Mugikura S, Umetsu A, et al. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 2006; 241: 839-46.10.1148/radiol.241305127617032910]Search in Google Scholar
[21. Ding Y, Xing Z, Liu B, Lin X, Cao D. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging. Brain and Behavior 2014; 4: 841-9.10.1002/brb3.288421211125365807]Search in Google Scholar
[22. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-4510.2307/2531595]Search in Google Scholar
[23. Kondziolka D, Bernstein M, Resch L, Tator CH, Fleming JF, Vanderlinden RG, et al. Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg 1987; 67: 852- 7.10.3171/jns.1987.67.6.08523316531]Search in Google Scholar
[24. Bagley LJ, Grossman RI, Judy KD, Curtis M, Loevner LA, Polansky M, et al. Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Radiology 1997; 202: 511-6.10.1148/radiology.202.2.90150829015082]Search in Google Scholar
[25. Li C, Ai B, Li Y, Qi H, Wu L. Susceptibility-weighted imaging in grading brain astrocytomas. Eur J Radiol 2010; 75: e81-5.10.1016/j.ejrad.2009.08.00319726149]Search in Google Scholar
[26. Furtner J, Schöpf V, Preusser M, Asenbaum U, Woitek R, Wöhrer A, et al. Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma. Eur J Radiol 2014; 83: 806-10.10.1016/j.ejrad.2014.01.01724613549]Search in Google Scholar
[27. Deckert M, Paulus W. Malignant lymphoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system. 4th ed. Lyon, France: International Agency for Research on Cancer, 2007. p. 188-92.]Search in Google Scholar
[28. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 2009; 30: 19-30.10.3174/ajnr.A1400380539119039041]Search in Google Scholar
[29. Mittal S, Wu Z, Neelavalli J, Haacke EM. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 2009; 30: 232-52.10.3174/ajnr.A1461380537319131406]Search in Google Scholar
[30. Nandigam RN, Viswanathan A, Delgado P, Skehan ME, Smith EE, Rosand J, et al. MR imaging detection of cerebral microbleeds: effect of susceptibility- weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol 2009; 30: 338-43.10.3174/ajnr.A1355276029819001544]Search in Google Scholar
[31. Wiggins GC, Triantafyllou C, Potthast A, Reykowski A, Nittka M, Wald LL. 32-channel 3 Tesla receive-only phased-array head coil with soccer-ball element geometry. Magn Reson Med 2006; 56: 216-23.10.1002/mrm.2092516767762]Search in Google Scholar
[32. Constable RT, Henkelman RM. Contrast, resolution, and detectability in MR imaging. J Comput Assist Tomogr 1991; 15: 297-303.10.1097/00004728-199103000-000212002111]Search in Google Scholar
[33. Kale SC, Chen XJ, Henkelman RM. Trading off SNR and resolution in MR images. NMR Biomed 2009; 22: 488-94.10.1002/nbm.135919123210]Search in Google Scholar
[34. Ahn SJ, Shin HJ, Chang JH, Lee SK. Differentiation between primary cerebral lymphoma and glioblastoma using the apparent diffusion coefficient: comparison of three different ROI Methods. PLoS One 2014; 9: e112948.10.1371/journal.pone.0112948423109925393543]Search in Google Scholar
[35. Matsushima N, Maeda M, Umino M, Suzawa N, Yamada T, Takeda K. Relation between FDG uptake and apparent diffusion coefficients in glioma and malignant lymphoma. Ann Nucl Med 2012; 26: 262-71.10.1007/s12149-012-0570-y22311413]Search in Google Scholar
[36. Weller M. Glucocorticoid treatment of primary CNS lymphoma. J Neurooncol 1999; 43: 237-9.10.1023/A:1006254518848]Search in Google Scholar
[37. Kim EY, Kim SS. Magnetic resonance findings of primary central nervous system T-cell lymphoma in immunocompetent patients. Acta Radiol 2005; 46: 187-92.10.1080/0284185051002271415902895]Search in Google Scholar
[38. Lee HY, Kim HS, Park JW, Baek HJ, Kim SJ, Choi CG. Atypical imaging features of epstein-barr virus-positive primary central nervous system lymphomas in patients without AIDS. AJNR Am J Neuroradiol 2013; 34: 1562-7.10.3174/ajnr.A3429805146523413244]Search in Google Scholar